Effect of a uterine manipulator on sexual function after total abdominal hysterectomy

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, single-center randomized controlled trial comparing total abdominal hysterectomy performed with a uterine manipulator to conventional abdominal hysterectomy without a manipulator. Women scheduled for hysterectomy for benign conditions who are sexually active and able to complete the Female Sexual Function Index (FSFI) are randomized and followed for outcomes. The primary outcome is FSFI score at 3 months after surgery, and secondary outcomes include operative time, perioperative hemoglobin change, postoperative pain (VAS), length of hospital stay, and 30-day complications. The trial is conducted at a tertiary training and research hospital in Istanbul with standardized perioperative care and follow-up visits for outcome collection.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Women aged ≥18 years
* Planned total abdominal hysterectomy for benign indications
* Sexually active within the last 4 weeks
* Able to complete the Female Sexual Function Index (FSFI) questionnaire
* Provided written informed consent

Exclusion Criteria:

* Gynecologic malignancy
* Major additional pelvic reconstructive surgery
* Severe psychiatric or neurologic disorder
* Inability to complete follow-up assessments

Where it's running

• Bakirkoy Dr. Sadi Konuk Training and Research Hospital
  Istanbul, Istanbul, Turkey (Türkiye) Recruiting

Study contacts

• Principal investigator: Erkan Göl, MD — University of Health Sciences, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Istanbul, Turkey
• Study coordinator: Erkan Göl, MD
• Email: drerkangol@gmail.com
• Phone: +905398517917

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• AI into Ultrasound Diagnostics in Reproductive Medicine

  Researchers are testing AI tools that analyze transvaginal ultrasound images to help detect endometriosis, adenomyosis, uterine masses, and pregnancy-related receptivity in women aged 18-45.

  Recruiting Semmelweis University · Budapest, Budapest · NCT07810920

• Ultrasound changes in fibroids during relugolix‑estradiol‑norethisterone treatment.

  This project will see if relugolix‑estradiol‑norethisterone changes the ultrasound appearance of fibroids in premenopausal women with heavy menstrual bleeding.

  Recruiting Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Roma · NCT06953076

• Comparing single-layer and double-layer closure techniques in cesarean sections

  This study is testing whether closing the uterus with one layer or two layers after a cesarean section affects the amount and length of spotting women experience afterward.

  Recruiting Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · Milan, Mi · NCT06308172

• IV Iron treatment for anemia in women with uterine bleeding

  This study is testing whether an IV iron treatment works better than oral iron for women with severe anemia caused by heavy bleeding.

  Recruiting Phase 3 Baylor College of Medicine · Houston, Texas · NCT05304442

• Platelet-rich plasma to prevent uterine scar problems after cesarean

  This test will see if applying your own platelet-rich plasma to the uterine incision at an elective term cesarean can reduce scar-related bleeding, pain, and menstrual problems.

  Recruiting The University of Texas Health Science Center, Houston · Ramat Gan, Center · NCT05224726

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.